DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 11, 2012, Pages 1648-1653

  Reuter, Morgan A ^a   Yuan, Sally ^a   Marx, Preston A ^b   Kutzler, Michele A ^c   Weiner, David B ^d   Betts, Michael R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Activation; DNA vaccine; HIV; Mucosal tissue; T cell

Indexed keywords

CD69 ANTIGEN; DNA VACCINE; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; FEMALE; GASTROINTESTINAL MUCOSA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INGUINAL LYMPH NODE; MUCOSAL IMMUNITY; NONHUMAN; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION;

ACTIVATION; DNA VACCINE; HIV; MUCOSAL TISSUE; T CELL;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MUCOUS MEMBRANE; T-LYMPHOCYTES; VACCINES, DNA;

EID: 84869814768     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22247     Document Type: Article

References (24)

1. Bukh I, Calcedo R, Roy S, Carnathan DG, Grant R, Ratcliffe SJ, et al. Increased mucosal CD4+ T cell activation following vaccination with an adenovirus vector in rhesus macaques. 29th Annual Nonhuman Primate Models for AIDS Symposium. Seattle, WA, 2011:Conference Presentation.
2. Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, et al. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J Virol 2012; 86:2239-50; PMID:22156519; http://dx.doi.org/10.1128/JVI.06175-11.
3. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-8; PMID:12368910; http://dx.doi.org/10.1038/ni845.
4. Hess C, Altfeld M, Thomas SY, Addo MM, Rosenberg ES, Allen TM, et al. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet 2004; 363:863-6; PMID:15031033; http://dx.doi.org/10.1016/ S0140-6736(04)15735-8.
5. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781-9; PMID:16467198; http://dx.doi.org/10.1182/blood- 2005-12-4818.
6. Hersperger AR, Migueles SA, Betts MR, Connors M. Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control. Curr Opin HIV AIDS 2011; 6:169-73; PMID:21399496; http://dx.doi.org/10.1097/COH. 0b013e3283454c39.
7. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al.; Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-93; PMID:19012954; http://dx.doi.org/10.1016/S0140-6736(08)61591-3.
8. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, et al.; Step Study Protocol Team. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894-905; PMID:19012957; http://dx.doi.org/10.1016/S0140-6736(08)61592-5.
9. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:1353-7; PMID:10558989; http://dx.doi.org/10. 1126/science.286.5443.1353.
10. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104:942-7; PMID:15117761; http://dx.doi.org/10.1182/blood-2003-09-3333.
11. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881-8; PMID:12960820; http://dx.doi.org/10. 1097/00002030-200309050-00006.
12. Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439-46; PMID:18301056; http://dx.doi.org/10.1097/QAD.0b013e3282f2dbe7.
13. Hutnick NA, Carnathan DG, Dubey SA, Cox KS, Kierstead L, Makadonas G, et al. Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. PLoS ONE 2010; 5:e14385; PMID:21203546; http://dx.doi.org/10.1371/journal.pone.0014385.
14. Hutnick NA, Carnathan DG, Dubey SA, Makedonas G, Cox KS, Kierstead L, et al. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nat Med 2009; 15:876-8; PMID:19620962; http://dx.doi.org/10.1038/nm.1989.
15. O'Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, et al. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat Med 2009; 15:873-5; PMID:19620961; http://dx.doi.org/ 10.1038/nm.1991.
16. Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, Hayes P, et al. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci USA 2009; 106:19940-5; PMID:19918060.
17. Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci USA 2007; 104:18648-53; PMID:18000037; http://dx.doi.org/10.1073/pnas.0709198104.
18. Chattergoon MA, Saulino V, Shames JP, Stein J, Montaner LJ, Weiner DB. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 2004; 22:1744-50; PMID:15068858; http://dx.doi.org/10.1016/j. vaccine.2004.01.036.
19. Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 2005; 175:112-23; PMID:15972637.
20. Kutzler MA, Weiner DB. Developing DNA vaccines that call to dendritic cells. J Clin Invest 2004; 114:1241-4; PMID:15520855.
21. McKay PF, Barouch DH, Santra S, Sumida SM, Jackson SS, Gorgone DA, et al. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses. Eur J Immunol 2004; 34:1011-20; PMID:15048711; http://dx.doi.org/10.1002/eji. 200324840.
22. Marsal J, Svensson M, Ericsson A, Iranpour AH, Carramolino L, Márquez G, et al. Involvement of CCL25 (TECK) in the generation of the murine small-intestinal CD8alpha alpha+CD3+ intraepithelial lymphocyte compartment. Eur J Immunol 2002; 32:3488-97; PMID:12442331; http://dx.doi.org/ 10.1002/1521-4141(200212)32:12〈3488::AIDIMMU3488〉3.0.CO;2-E.
23. Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M, et al. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 2006; 107:3447-54; PMID:16391017; http://dx.doi.org/10.1182/blood-2005-07-2860.
24. Svensson M, Johansson-Lindbom B, Wurbel MA, Malissen B, Márquez G, Agace W. Selective generation of gut-tropic T cells in gut-associated lymphoid tissues: requirement for GALT dendritic cells and adjuvant. Ann N Y Acad Sci 2004; 1029:405-7; PMID:15681793; http://dx.doi.org/10.1196/annals.1309.025.